Table IV.
Low-risk patients, n=137 | High-risk patients, n=190 | |||||
---|---|---|---|---|---|---|
|
|
|||||
Characteristic | Level Ib unirradiated | Level Ib irradiated | P-value | Level Ib unirradiated | Level Ib irradiated | P-value |
Age | ||||||
≤45 | 38 | 31 | 0.395 | 40 | 54 | 0.658 |
>45 | 32 | 36 | 37 | 59 | ||
Gender | ||||||
Male | 46 | 48 | 0.468 | 54 | 78 | 1.000 |
Female | 24 | 19 | 23 | 35 | ||
Clinical stage | ||||||
I | 17 | 6 | 0.091 | 0 | 0 | 0.105 |
II | 24 | 28 | 23 | 21 | ||
III | 18 | 17 | 30 | 60 | ||
IV | 11 | 16 | 24 | 32 | ||
T classification | ||||||
T1 | 18 | 10 | 0.349 | 7 | 11 | 0.176 |
T2 | 24 | 26 | 36 | 36 | ||
T3 | 17 | 15 | 19 | 42 | ||
T4 | 11 | 16 | 15 | 24 | ||
N classification | ||||||
N0 | 53 | 41 | 0.101 | 0 | 0 | 0.028 |
N1 | 15 | 19 | 43 | 51 | ||
N2 | 2 | 7 | 23 | 54 | ||
N3 | 0 | 0 | 11 | 8 | ||
Chemotherapy | ||||||
No | 47 | 44 | 0.859 | 19 | 39 | 0.199 |
Yes | 23 | 23 | 58 | 74 |